Orthogonal develops medical device software enabling connected healthcare solutions and improved patient outcomes.
Orthogonal has raised $4.3M in total funding. The most recent round was Seed. The last funding was announced in June 2026.
Orthogonal's investors include Y Combinator, Pioneer Fund, Pantera Capital, Blast. Club, Decasonic.
Orthogonal is headquartered in San Francisco, United States.
Orthogonal develops medical device software enabling connected healthcare solutions and improved patient outcomes.
Orthogonal is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Orthogonal — Funding & Investors." VCBacked, June 22, 2026, https://www.vcbacked.co/company/orthogonal-san-francisco. Accessed September 2, 2026.
VCBacked. (2026). Orthogonal — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/orthogonal-san-francisco
{{cite web |title=Orthogonal — Funding & Investors |url=https://www.vcbacked.co/company/orthogonal-san-francisco |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated